How can CBD compete with medication?
In a strategic initiative to unify its brand identity, Alivium CBD, a distinguished line of recovery products from The Beemine Lab, underwent a comprehensive rebranding. This effort aimed to merge Alivium’s iconic market presence with the overarching image of The Beemine Lab, ensuring the two brands complement each other seamlessly.
The rebranding encompassed all aspects of product presentation, including tubes, cases, and displays. The new design reflects The Beemine Lab’s aesthetic and values, creating a cohesive brand experience. The updated, multilingual packaging addresses previous logistical challenges, enhancing international market accessibility while maintaining Alivium’s distinctive traits to preserve customer trust.
Central to the rebranding was the alignment of typography across products, utilizing The Beemine Lab’s font for coherence. The design incorporated scientific and laboratory-inspired graphics to reinforce Alivium’s reputation as a trusted pain relief solution, drawing inspiration from pharmaceutical layouts to lend a professional, reliable look.
An innovative feature of the new packaging is the inclusion of four languages, facilitating smoother global distribution and ensuring clarity for users worldwide. This approach not only solved past logistical issues but also enhanced product accessibility across diverse markets.
Through this rebranding, Alivium CBD not only strengthened its identity alongside The Beemine Lab but also solidified its position as a leader in innovative recovery solutions, symbolizing a perfect blend of tradition and modernity.